Lupin Ltd

LUPIN

Company Profile

  • Business description

    Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.

  • Contact

    Off. Western Express Highway
    3rd floor, Kalpataru Inspire
    Santacruz (East)
    MumbaiMH400055
    IND

    T: +91 2266402323

    E: [email protected]

    https://www.lupin.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    24,006

Stocks News & Analysis

stocks

Cheap ASX share pays a heavy price for NRL rights

Growth has slowed amid increased competition for viewers and content.
stocks

The World Cup stock you’ve never heard of

This ASX stock is kicking goals at the FIFA World Cup.
stocks

Chart of the Week: Can WiseTech shares finally bounce back?

Market concerns over governance and AI fears have left shares trading well below the fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,003.7034.900.39%
CAC 408,338.9712.350.15%
DAX 4025,067.0951.18-0.20%
Dow JONES (US)52,637.01149.600.29%
FTSE 10010,497.2924.840.24%
HKSE24,175.12144.940.60%
NASDAQ26,281.6174.720.29%
Nikkei 22568,557.73813.881.20%
NZX 50 Index13,785.67120.490.88%
S&P 5007,575.3931.750.42%
S&P/ASX 2008,806.0038.200.44%
SSE Composite Index3,996.1640.43-1.00%

Market Movers